The US Air Force (USAF) 780^th Test Squadron, based at Eglin Air Force Base (AFB), Florida has successfully conducted the first arena test of the warhead intended to equip the Lockheed Martin AGM-183A Air-Launched Rapid Response Weapon (ARRW) prototype conventional hypersonic glide weapon system.

The AGM-183A ARRW is a rapid prototyping middle-tier acquisition (MTA) programme for the USAF that leverages performance data from the separate Defense Advanced Research Projects Agency (DARPA)/USAF Tactical Boost Glide (TBG) programme. The ARRW programme plans to develop an operational prototype, with a solid-fuel booster and conventional ordnance package, which will be carried on the B-52H strategic bomber. The USAF's Global Strike Command is also evaluating integration of the AGM-183A on the external weapons stores of the B-1 Lancer strategic bomber.

Intended to collect lethality data on developmental AGM-183A weapon, the detonation test was designed and conducted “to ensure the customer's data requirements were met using new and improved test tools, technologies, and techniques”, according to a USAF statement released on 7 July.

“The unique nature and shape of the warhead required a lot of firsts for everyone involved,” said 780^th

The US Air Force (USAF) 780^th Test Squadron, based at Eglin Air Force Base (AFB), Florida has successfully conducted the first arena test of the warhead intended to equip the Lockheed Martin AGM-183A Air-Launched Rapid Response Weapon (ARRW) prototype conventional hypersonic glide weapon system.

The AGM-183A ARRW is a rapid prototyping middle-tier acquisition (MTA) programme for the USAF that leverages performance data from the separate Defense Advanced Research Projects Agency (DARPA)/USAF Tactical Boost Glide (TBG) programme. The ARRW programme plans to develop an operational prototype, with a solid-fuel booster and conventional ordnance package, which will be carried on the B-52H strategic bomber. The USAF's Global Strike Command is also evaluating integration of the AGM-183A on the external weapons stores of the B-1 Lancer strategic bomber.

Intended to collect lethality data on developmental AGM-183A weapon, the detonation test was designed and conducted “to ensure the customer's data requirements were met using new and improved test tools, technologies, and techniques”, according to a USAF statement released on 7 July.

“The unique nature and shape of the warhead required a lot of firsts for everyone involved,” said 780^th

The US Air Force (USAF) 780^th Test Squadron, based at Eglin Air Force Base (AFB), Florida has successfully conducted the first arena test of the warhead intended to equip the Lockheed Martin AGM-183A Air-Launched Rapid Response Weapon (ARRW) prototype conventional hypersonic glide weapon system.

The AGM-183A ARRW is a rapid prototyping middle-tier acquisition (MTA) programme for the USAF that leverages performance data from the separate Defense Advanced Research Projects Agency (DARPA)/USAF Tactical Boost Glide (TBG) programme. The ARRW programme plans to develop an operational prototype, with a solid-fuel booster and conventional ordnance package, which will be carried on the B-52H strategic bomber. The USAF's Global Strike Command is also evaluating integration of the AGM-183A on the external weapons stores of the B-1 Lancer strategic bomber.

Intended to collect lethality data on developmental AGM-183A weapon, the detonation test was designed and conducted “to ensure the customer's data requirements were met using new and improved test tools, technologies, and techniques”, according to a USAF statement released on 7 July.

“The unique nature and shape of the warhead required a lot of firsts for everyone involved,” said 780^th

The US Air Force (USAF) 780^th Test Squadron, based at Eglin Air Force Base (AFB), Florida has successfully conducted the first arena test of the warhead intended to equip the Lockheed Martin AGM-183A Air-Launched Rapid Response Weapon (ARRW) prototype conventional hypersonic glide weapon system.

The AGM-183A ARRW is a rapid prototyping middle-tier acquisition (MTA) programme for the USAF that leverages performance data from the separate Defense Advanced Research Projects Agency (DARPA)/USAF Tactical Boost Glide (TBG) programme. The ARRW programme plans to develop an operational prototype, with a solid-fuel booster and conventional ordnance package, which will be carried on the B-52H strategic bomber. The USAF's Global Strike Command is also evaluating integration of the AGM-183A on the external weapons stores of the B-1 Lancer strategic bomber.

Intended to collect lethality data on developmental AGM-183A weapon, the detonation test was designed and conducted “to ensure the customer's data requirements were met using new and improved test tools, technologies, and techniques”, according to a USAF statement released on 7 July.

“The unique nature and shape of the warhead required a lot of firsts for everyone involved,” said 780^th

The US Air Force (USAF) 780^th Test Squadron, based at Eglin Air Force Base (AFB), Florida has successfully conducted the first arena test of the warhead intended to equip the Lockheed Martin AGM-183A Air-Launched Rapid Response Weapon (ARRW) prototype conventional hypersonic glide weapon system.

The AGM-183A ARRW is a rapid prototyping middle-tier acquisition (MTA) programme for the USAF that leverages performance data from the separate Defense Advanced Research Projects Agency (DARPA)/USAF Tactical Boost Glide (TBG) programme. The ARRW programme plans to develop an operational prototype, with a solid-fuel booster and conventional ordnance package, which will be carried on the B-52H strategic bomber. The USAF's Global Strike Command is also evaluating integration of the AGM-183A on the external weapons stores of the B-1 Lancer strategic bomber.

Intended to collect lethality data on developmental AGM-183A weapon, the detonation test was designed and conducted “to ensure the customer's data requirements were met using new and improved test tools, technologies, and techniques”, according to a USAF statement released on 7 July.

“The unique nature and shape of the warhead required a lot of firsts for everyone involved,” said 780^th

The US Air Force (USAF) 780^th Test Squadron, based at Eglin Air Force Base (AFB), Florida has successfully conducted the first arena test of the warhead intended to equip the Lockheed Martin AGM-183A Air-Launched Rapid Response Weapon (ARRW) prototype conventional hypersonic glide weapon system.

The AGM-183A ARRW is a rapid prototyping middle-tier acquisition (MTA) programme for the USAF that leverages performance data from the separate Defense Advanced Research Projects Agency (DARPA)/USAF Tactical Boost Glide (TBG) programme. The ARRW programme plans to develop an operational prototype, with a solid-fuel booster and conventional ordnance package, which will be carried on the B-52H strategic bomber. The USAF's Global Strike Command is also evaluating integration of the AGM-183A on the external weapons stores of the B-1 Lancer strategic bomber.

Intended to collect lethality data on developmental AGM-183A weapon, the detonation test was designed and conducted “to ensure the customer's data requirements were met using new and improved test tools, technologies, and techniques”, according to a USAF statement released on 7 July.

“The unique nature and shape of the warhead required a lot of firsts for everyone involved,” said 780^th